Efficacy of phosphodiesterase inhibition with milrinone in combination with converting enzyme inhibitors in patients with heart failure

This publication has 11 references indexed in Scilit:

• Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Results of a multicenter trial. The Pimobendan Multicenter Research Group.
  Circulation, 1992
• Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
  New England Journal of Medicine, 1991
• Usefulness of OPC-8212, a quinolinone derivative, for chronic congestive heart failure in patients with ischemic heart disease or idiopathic dilated cardiomyopathy
  The American Journal of Cardiology, 1991
• A Comparison of Oral Milrinone, Digoxin, and Their Combination in the Treatment of Patients with Chronic Heart Failure
  New England Journal of Medicine, 1989
• Application of a frequency definition of ventricular proarrhythmia
  The American Journal of Cardiology, 1987
• Immediate effects of milrinone on metabolic and sympathetic responses to exercise in severe congestive heart failure
  The American Journal of Cardiology, 1985
• Evaluation of a New Bipyridine Inotropic Agent — Milrinone — in Patients with Severe Congestive Heart Failure
  New England Journal of Medicine, 1983
• Characterization of the Cardiotonic Effects of Milrinone, a New and Potent Cardiac Bipyridine, on Isolated Tissues from Several Animal Species
  Journal of Cardiovascular Pharmacology, 1983
• Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.
  Circulation, 1983
• Treadmill exercise in assessment of the functional capacity of patients with cardiac disease
  The American Journal of Cardiology, 1972